Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Alternative therapeutic strategies to treat antibiotic-resistant pathogens
Resistance threatens to render antibiotics—which are essential for modern medicine—
ineffective, thus posing a threat to human health. The discovery of novel classes of …
ineffective, thus posing a threat to human health. The discovery of novel classes of …
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
M Chehelgerdi, M Chehelgerdi… - Molecular cancer, 2024 - Springer
The CRISPR system is a revolutionary genome editing tool that has the potential to
revolutionize the field of cancer research and therapy. The ability to precisely target and edit …
revolutionize the field of cancer research and therapy. The ability to precisely target and edit …
Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice
Antibiotic treatments have detrimental effects on the microbiome and lead to antibiotic
resistance. To develop a phage therapy against a diverse range of clinically relevant …
resistance. To develop a phage therapy against a diverse range of clinically relevant …
Novel CRISPR–Cas systems: an updated review of the current achievements, applications, and future research perspectives
According to Darwin's theory, endless evolution leads to a revolution. One such example is
the Clustered Regularly Interspaced Palindromic Repeats (CRISPR)–Cas system, an …
the Clustered Regularly Interspaced Palindromic Repeats (CRISPR)–Cas system, an …
[HTML][HTML] Advances in industrial biotechnology using CRISPR-Cas systems
PD Donohoue, R Barrangou, AP May - Trends in biotechnology, 2018 - cell.com
The term 'clustered regularly interspaced short palindromic repeats'(CRISPR) has recently
become synonymous with the genome-editing revolution. The RNA-guided endonuclease …
become synonymous with the genome-editing revolution. The RNA-guided endonuclease …
High‐efficiency delivery of CRISPR‐Cas9 by engineered probiotics enables precise microbiome editing
K Neil, N Allard, P Roy, F Grenier… - Molecular Systems …, 2021 - embopress.org
Antibiotic resistance threatens our ability to treat infectious diseases, spurring interest in
alternative antimicrobial technologies. The use of bacterial conjugation to deliver CRISPR …
alternative antimicrobial technologies. The use of bacterial conjugation to deliver CRISPR …
Conjugative delivery of CRISPR-Cas9 for the selective depletion of antibiotic-resistant enterococci
M Rodrigues, SW McBride, K Hullahalli… - Antimicrobial Agents …, 2019 - journals.asm.org
The innovation of new therapies to combat multidrug-resistant (MDR) bacteria is being
outpaced by the continued rise of MDR bacterial infections. Of particular concern are …
outpaced by the continued rise of MDR bacterial infections. Of particular concern are …
[HTML][HTML] Engineering therapeutic phages for enhanced antibacterial efficacy
The alarming rise in antimicrobial resistance coupled with a lack of innovation in antibiotics
has renewed interest in the development of alternative therapies to combat bacterial …
has renewed interest in the development of alternative therapies to combat bacterial …
Advancements in bacteriophage therapies and delivery for bacterial infection
Having co-evolved with bacteria over hundreds of millions of years, bacteriophage are
effective killers of specific bacterial hosts. Therefore, phage therapies for infection are a …
effective killers of specific bacterial hosts. Therefore, phage therapies for infection are a …
[HTML][HTML] CRISPR-Cas: Converting a bacterial defence mechanism into a state-of-the-art genetic manipulation tool
A Loureiro, GJ da Silva - Antibiotics, 2019 - mdpi.com
Bacteriophages are pervasive viruses that infect bacteria, relying on their genetic machinery
to replicate. In order to protect themselves from this kind of invader, bacteria developed an …
to replicate. In order to protect themselves from this kind of invader, bacteria developed an …